Skip to main content
SpringerLink
Log in

Evaluation of Male Sexual Dysfunction

  • Chapter
  • First Online:
Cancer and Sexual Health

Part of the book series: Current Clinical Urology ((CCU))

  • 1594 Accesses

Abstract

The management of male sexual dysfunction and specifically erectile dysfunction (ED) has seen major changes in each decade since the 1970s thanks to the discovery that a papaverine injection could produce erection, the NIH Consensus Statement which defined ED in 1992, advances in minimally invasive diagnostics, and the development of orally effective erectogenic class of drugs, the phosphodiesterase type-5 inhibitors (PDE-5 Inhs). As a result the health care professionals most frequently consulted have also changed from the psychologists to the urologists and now to the primary care clinicians (PCC), who are the most frequent prescribers of the PDE-5 Inhs. The evaluation and management of male sexual dysfunctions may come under the purview of many different providers besides PCCs including cardiology, urology, endocrinology, psychiatry, psychology, and neurology and allied health care professionals. Unfortunately, many providers are reluctant to ask patients about sexual health. Identification of sexual dysfunctions has been hampered by traditional and difficult to overcome barriers: embarrassment, lack of expertise in sexual history taking, concerns about the safety of ED treatments, and lack of time. Studies have documented both patient and physician misconceptions [1].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 219.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 279.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Tsimtsiou Z, Hatzimouratidis K, Nakopoulou E, Kyrana E, Salpigidis G, Hatzichristou D. Predictors of physicians’ involvement in addressing sexual health issues. J Sex Med. 2006;3(4):583–8.

    PubMed  Google Scholar 

  2. Marwick C. Survey says patient expect little physician help on sex. JAMA. 1999;28(23):2173–4.

    Google Scholar 

  3. Ries LAG, Melbert D, Krapcho M, et al. SEER cancer statistics review, 1975–2005. Bethesda: National Cancer Institute; 2005. http//seer.cancer.gov/csr/1975_2005/.

  4. Hewitt M, Greenfield S, Stovall E, editors. From cancer patient to cancer survivor: lost in transition. Washington, DC: The National Academies Press; 2006.

    Google Scholar 

  5. Kornblith AB, Ligibel J. Psychosocial and sexual function of survivors of breast cancer. Semin Oncol. 2003;30(6):799–813.

    PubMed  Google Scholar 

  6. Siegel T, Moul JW, Spevak M, Alvord WG, Costagbile RA. The development of erectile dysfunction in men treated for prostate cancer. J Urol. 2001;165(2):430–5.

    PubMed  CAS  Google Scholar 

  7. Kornblith AB, Anderson J, Cella DF, et al. Hodgkin disease survivors at increased risk for problems in psychosocial adaptation. Cancer. 1992;70(8):2214–24.

    PubMed  CAS  Google Scholar 

  8. Monga U, Tan G, Ostermann HJ, Monga TN. Sexuality in head and neck cancer patient. Arch Phys Med Rehabil. 1997;78(3):298–304.

    PubMed  CAS  Google Scholar 

  9. Park ER, Bober SL, Campbell EG, Recklitis CJ, Kutner JS, Diller L. General internist communication about sexual function with cancer survivors. J Gen Intern Med. 2009;24(Supl 2):407–11.

    Google Scholar 

  10. Huyghe E, Sui D, Odensky E, Schover LR. Needs assessment survey to justify establishing a reproductive health clinic at a comprehensive cancer center. J Sex Med. 2009;6:149–63.

    PubMed  Google Scholar 

  11. Lue TF. Impotence: a patient’s goal-directed approach to treatment. World J Urol. 1990;8:67.

    Google Scholar 

  12. Jardin A, Wagner G, Khoury S, et al. Erectile dysfunction: first international consultation on erectile dysfunction. Plymouth: Health Publications; 2000. p. 711–23.

    Google Scholar 

  13. Rosen RC, Hatzichristou D, Broderick G, et al. Clinical evaluation and symptom scales: sexual dysfunction assessment in men. In: Lue TF, Basson R, Rosen R, et al., editors. Sexual medicine: sexual dysfunctions in men and women. Paris: Health Publications; 2004. p. 173–220.

    Google Scholar 

  14. Geirteis M, Edgman-Levitan S, Daley J, et al. Medicine and health from the patient’s perspective. In through the patient’s eyes. San Francisco: Jossey-Bass; 1993. p. 1–15.

    Google Scholar 

  15. Lue TF, Broderick GA. Evaluation and nonsurgical management of erectile dysfunction and premature ejaculation. In: Wein AJ, editor. Campell-Walsh urology. 9th ed. Philadelphia: Saunders; 2007. p. 750–87.

    Google Scholar 

  16. Hatzichristou D, Rosen RC, Derogatis LR, Low WY, Meuleman EJH, Sadovsky R, et al. Recommen­dations for the clinical evaluation of men and women with sexual dysfunction. J Sex Med. 2010;7:337–48. Retrived from www.issm.info

    PubMed  Google Scholar 

  17. Fineman KR, Rettinger HI. Development of the male function profile/impotence questionnaire. Psychol Rep. 1991;68:1151–75.

    PubMed  CAS  Google Scholar 

  18. Geiser ME, Murray FT, Cohen MS, et al. Use of the Florida Sexual History Questionnaire to differentiate primary organic from primary psychogenic impotence. J Androl. 1993;14:298–303.

    Google Scholar 

  19. Speckens AE, Hengeveld MW, Lycklama a Nijeholt GA, et al. Discrimination between psychogenic and organic erectile dysfunction. J Psychosom Res. 1993;37:135–45.

    PubMed  CAS  Google Scholar 

  20. Corty EW, Althof SE, Kurit DM. The reliability and validity of a sexual functioning questionnaire. J Sex Marital Ther. 1996;22:27–34.

    PubMed  CAS  Google Scholar 

  21. Rosen RC, Riley A, Wagner G, et al. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997;49:822–30.

    PubMed  CAS  Google Scholar 

  22. O’leary MP, Fowler FJ, Lenderkin WR, Barber B, et al. A brief sexual function inventory for urology. Urology. 1996;47(5):782–3.

    Google Scholar 

  23. Althof SE, Corty EW, Levine SB, et al. EDITS: development of questionnaires for evaluating satisfaction with treatments for erectile dysfunction. Urology. 1999;53:793–9.

    PubMed  CAS  Google Scholar 

  24. Derogatis LR, Melisaratos N. The DSFI: a multidimensional measure of sexual functioning. J Sex Marital Ther. 1979;5:244.

    PubMed  CAS  Google Scholar 

  25. Glick HA, McCarron TJ, Althof SE, et al. Construction of scales for the Center for Marital and Sexual Health (CMASH) Sexual Functioning Questionnaire. J Sex Marital Ther. 1997;23:103–17.

    PubMed  CAS  Google Scholar 

  26. Rosen RC. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function as a diagnostic toll for erectile dysfunction. Int J Impot Res. 1999;11:319–26.

    PubMed  CAS  Google Scholar 

  27. National Institutes of Health (NIH) Consensus Development Panel on Impotence. JAMA. 1993;270(1):83–90.

    PubMed  CAS  Google Scholar 

  28. Cappelleri JC, Althof SE, Siegel RL, et al. Development and validation of the Self-Esteem and Relationship (SEAR) questionnaire in erectile dysfunction. Int J Impot Res. 2004;16:30–8.

    PubMed  CAS  Google Scholar 

  29. Donovan KA, Thompson LMA, Hoffe SE. Sexual function in colorectal cancer survivors. Cancer Control. 2010;17(1):44–51.

    PubMed  Google Scholar 

  30. National Comprehensive Cancer Network NCCN. Clinical practice guidelines in oncology, prostate cancer. V.2.2009. http://www.nccn.org.

  31. Mulhall JP. Defining and reporting erectile function outcomes after radical prostatectomy: challenges and misconceptions. J Urol. 2009;181:462–71.

    PubMed  Google Scholar 

  32. Walz J, Perrotte P, Suardi N, et al. Baseline prevalence of erectile dysfunction in a prostate cancer screening population. J Sex Med. 2008;5:428–35.

    PubMed  Google Scholar 

  33. Blander DS, Sanchez-Ortiz RF, Broderick GA. Sex inventories: can questionnaires replace erectile dysfunction testing? Urology. 1999;54:719–23.

    PubMed  CAS  Google Scholar 

  34. Thompson IM, Tangen CM, Goodman PJ, Monipour CM. Erectile dysfunction and subsequent cardiovascular disease. JAMA. 2005;294(23):2996–3002.

    PubMed  CAS  Google Scholar 

  35. Nehra A. Erectile dysfunction and cardiovascular disease: efficacy and safety of phosphodiesterase type 5 inhibitors in men with both conditions. Mayo Clin Proc. 2009;84(2):139–48.

    PubMed  CAS  Google Scholar 

  36. Inman BA, St Sauver JL, Jacobson DF, et al. A population-based longitudinal study of erectile dysfunction and future coronary artery disease. Mayo Clin Proc. 2009;84(2):108–13.

    PubMed  Google Scholar 

  37. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NECP). Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486–97.

    Google Scholar 

  38. Armenakas NA, McAninch JW, Lue TF, et al. Posttraumatic impotence: magnetic resonance imaging and duplex ultrasound in diagnosis and management. J Urol. 1993;149:1272–5.

    PubMed  CAS  Google Scholar 

  39. Walsh PC, Partin AW, Epstein JI. Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years. J Urol. 1994;152:1831–6.

    PubMed  CAS  Google Scholar 

  40. Rosen R, Altwein J, Boyle P, Kirby RS, et al. Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol. 2003;44(6):637–49.

    PubMed  Google Scholar 

  41. Althof SE. When an erection alone is not enough: biopsychosocial obstacle to lovemaking. Int J Impot Res. 2002;14 Suppl 1:S99–140.

    PubMed  Google Scholar 

  42. Dunn ME. Restoration of couple’s intimacy and relationship is vital to reestablishing erectile function. J Am Osteopath Assoc. 2004;104 Suppl 4:S6–10.

    PubMed  Google Scholar 

  43. Hartmann U. Psychological evaluation and psychometry. In: Jonas U, Thon WF, Stief CG, editors. Erectile dysfunction. Berlin: Springer; 1991. p. 93–103.

    Google Scholar 

  44. Mohr DC, Beutler LE, Engle D, et al. Identification of patients at risk for nonresponse and negative outcome fore psychotherapy. J Consult Clin Psychol. 1990;58(5):622–8.

    PubMed  CAS  Google Scholar 

  45. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA. 1999;281:537.

    PubMed  CAS  Google Scholar 

  46. Hengeveld MW. Erectile disorder: a psychosexological review. In: Jonas U, Thon WF, Stief CG, editors. Erectile dysfunction. Berlin: Springer; 1991.

    Google Scholar 

  47. Perelman MA. The impact of new sexual pharmaceuticals on sex therapy. Curr Psychiatry Rep. 2001;3:195–201.

    PubMed  CAS  Google Scholar 

  48. Seftel AD. Diagnosis of erectile dysfunction. In: Porst H, Buvat J, editors. Standard practice in sexual medicine. Malden: Blackwell; 2006. p. 59–74.

    Google Scholar 

  49. Wang C, Nieschag E, Swerdloff R, et al. Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendation. Eur Urol. 2009;55:121–30.

    PubMed  Google Scholar 

  50. Schopohl J, Mojto J, Sosa M, Mehltretter G, Muller OA, von Werder K. Changes in anterior pituitary response in patients with idiopathic hypothalamic hypogonadism caused by pulsatile GnRH therapy and testosterone replacement. Exp Clin Endocrinol Diabetes. 1995;103(3):184–90.

    PubMed  CAS  Google Scholar 

  51. Mooradian AD, Morley JE, Korenman SG. Biological actions of androgens. Endocr Rev. 1987;8:1–28.

    PubMed  CAS  Google Scholar 

  52. Basaria S, Dobs AS. Hypogonadism and androgen replacement therapy in elderly men. Am J Med. 2001;110:563–72.

    PubMed  CAS  Google Scholar 

  53. Freeman ER, Bloom DA, McGuire EJ. A brief history of testosterone. J Urol. 2001;165:371–3.

    PubMed  CAS  Google Scholar 

  54. Rosner W, Auchus RJ, Azziz R, et al. Position statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab. 2007;92(2):405–13.

    PubMed  CAS  Google Scholar 

  55. Kropman RF, Verdijk RM, Lycklamaa Nijeholt AA, et al. Routine endocrine screening in impotence: significance and cost-effectiveness. Int J Impot Res. 1991;3:87.

    Google Scholar 

  56. Johnson AR, Jarow JP. Is routine endocrine testing of impotent men necessary? J Urol. 1992;147:1542.

    PubMed  Google Scholar 

  57. Buvat J, Lemaire A. Endocrine screening in 1022 men with erectile dysfunction: clinical significance and cost-effective strategy. J Urol. 1997;158:1764.

    PubMed  CAS  Google Scholar 

  58. Johri AM, Heaton JP, Morales A. Severe erectile dysfunction is a marker for hyperprolactinemia. Int J Impot Res. 2001;13(3):176–82.

    PubMed  CAS  Google Scholar 

  59. Buvat J. Hormones et comportement sexuel de l’homme: Données physiologiques et physiopathologiques. Contracept Fertil Sex. 1996;24:767.

    PubMed  CAS  Google Scholar 

  60. Greenfield DM, Walters SJ, Coleman RE, et al. Prevalence and consequences of androgen deficiency in young male cancer survivors in a controlled cross-sectional study. J Clin Endocrinol Metab. 2007;92:3476–82.

    PubMed  CAS  Google Scholar 

  61. Fossa SD, Dahl AA, Loge JH. Fatigue, anxiety and depression in long-term survivors of testicular cancer. J Clin Oncol. 2003;21:1249–54.

    PubMed  Google Scholar 

  62. Hudaart RA, Norman A, Moynihan C, et al. Fertility, gonadal and sexual function in survivors of testicular cancer. Br J Cancer. 2005;93:200–7.

    Google Scholar 

  63. Nazareth I, Lewin J, King M. Sexual dysfunction after treatment for testicular cancer: a systematic review. J Psychosom Res. 2001;51:735–43.

    PubMed  CAS  Google Scholar 

  64. Ebberhard J, Stahl O, Cohn-Cedermark G, et al. Sexual function in men treated for testicular cancer. J Sex Med. 2009;6:1979–89.

    Google Scholar 

  65. Greenfield DM, Walters SJ, Coleman RE, Hancock BW, Snowden JA, Shalet SM, et al. Quality of life, self-esteem, fatigue and sexual function in young men after cancer. Cancer. 2010;116(6):1592–601.

    PubMed  Google Scholar 

  66. Donatucci CF, Lue TF. The combined intracavernous injection and stimulation test: diagnostic accuracy. J Urol. 1992;148:61–2.

    PubMed  CAS  Google Scholar 

  67. Katlowitz NM, Albano GJ, Morales P, et al. Potentiation of drug-induced erection with audiovisual sexual stimulation. Urology. 1993;41:431–4.

    PubMed  CAS  Google Scholar 

  68. Pescatori ES, Hatzichristou DG, Namburi S, et al. A positive intracavernous injection test implies normal veno-occlusive but not necessarily normal arterial function: a hemodynamic study. J Urol. 1994;151:1209–16.

    PubMed  CAS  Google Scholar 

  69. Broderick GA, Arger P. Duplex Doppler ultrasonography: noninvasive assessment of penile anatomy and function. Semin Roentgenol. 1993;28:43–56.

    PubMed  CAS  Google Scholar 

  70. Herbner TE, Seftel AD, Nehra A, et al. Penile ultrasound. Semin Urol. 1994;12:320–32.

    Google Scholar 

  71. Landwehr P. Penile vessels: erectile dysfunction. In: Wolf K-J, Fobbe F, editors. Color Duplex sonography: principles and clinical application. Stuttgart: Thieme Medical; 1995. p. 204–15.

    Google Scholar 

  72. Cappelleri JC, Bushmakin AG, Symonds T, Schnetzler G. Scoring correspondence in outcomes related to erectile dysfunction treatment on a 4-point scale (SCORE-4). J Sex Med. 2009;6(3):809–19.

    PubMed  Google Scholar 

  73. Arsian D, Esen AA, Secil M, et al. A new method for the evaluation of erectile dysfunction: sildenafil plus Doppler ultrasonography. J Urol. 2001;166(1):181–4.

    Google Scholar 

  74. Erdogru T, Usta MF, Ceken K, et al. Is sildenafil citrate an alternative agent in the evaluation of penile vascular system with color Doppler ultrasound. Urol Int. 2002;68(4):255–60.

    PubMed  CAS  Google Scholar 

  75. Copel L, Katz R, Blachar A, et al. Clinical and duplex US assessment of effects of sildenafil on cavernosal arteries of the penis: comparison with intracavernosal injection of vasoactive agent – initial experience. Radiology. 2005;237(3):986–91.

    PubMed  Google Scholar 

  76. Schwartz AN, Lowe M, Berger RE, et al. Assessment of normal and abnormal erectile function: color Doppler flow sonography versus conventional techniques. Radiology. 1991;180:105–9.

    PubMed  CAS  Google Scholar 

  77. Lue TF, Hricak H, Marich KW, et al. Vasculogenic impotence evaluated by high-resolution ultrasonography and pulsed Doppler spectrum analysis. Radiology. 1985;155:777–81.

    PubMed  CAS  Google Scholar 

  78. Mueller SC, Lue TF. Evaluation of vasculogenic impotence. Urol Clin North Am. 1988;15:65–76.

    PubMed  CAS  Google Scholar 

  79. Broderick GA, Lue TF. The penile blood flow study: evaluation of vasculogenic impotence. In: Jonas U, Thon WF, Stief CG, editors. Erectile dysfunction. Berlin: Springer; 1991. p. 126–36.

    Google Scholar 

  80. Shabsigh R, Fishman IJ, Shotland Y, et al. Comparison of penile duplex ultrasonography with nocturnal penile tumescence monitoring for the evaluation of erectile impotence. J Urol. 1990;143:924–7.

    PubMed  CAS  Google Scholar 

  81. Benson CB, Vickers MA. Sexual impotence caused by vascular disease: diagnosis with duplex sonography. AJR Am J Roentgenol. 1989;153:1149–53.

    PubMed  CAS  Google Scholar 

  82. Lewis RW, King BF. Dynamic color Doppler sonography in the evaluation of penile erectile disorders [Abstract]. Int J Impot Res. 1994;6:A30.

    Google Scholar 

  83. Lue TF, Tanagho EA. Physiology of erection and pharmacological management of impotence. J Urol. 1987;137:829–36.

    PubMed  CAS  Google Scholar 

  84. Planiol T, Pourcelot L. Doppler effect study on the carotid circulation. In: de Vlieger M, White DN, McCready VR, eds. Ultrasonics in Medicine. Excerpta Medica, Amsterdam; 1974. p. 104–111.

    Google Scholar 

  85. Zimmern PE, Kaswick J, Leach GE. How potent is potent before nerve-sparing radical retropubic prostatectomy. J Urol. 1995;154:1100–1.

    PubMed  CAS  Google Scholar 

  86. Halverson HM. Genital and sphincter behavior of the male infant. J Gen Psychol. 1940;56:95.

    Google Scholar 

  87. Karacan I, Hursch CJ, Williams RI. Some characteristics of nocturnal penile tumescence in elderly males. J Gerontol. 1972;27:39.

    PubMed  CAS  Google Scholar 

  88. Karacan I. Clinical value of nocturnal erection in the prognosis and diagnosis of impotence. Med Aspects Hum Sex. 1970;4:27.

    Google Scholar 

  89. Karacan I. NPT/rigidometry. In: Kirby RS, Carson CC, Webster GD, editors. Impotence: diagnosis and management of male erectile dysfunction. Oxford: Butterworth-Heinemann; 1991. p. 62–71.

    Google Scholar 

  90. Bradley WE, Timm GW, Gallagher JM, et al. New method for continuous measurement of nocturnal penile tumescence and rigidity. Urology. 1985;26:4–9.

    PubMed  CAS  Google Scholar 

  91. Levine LA, Lenting EL. Use of nocturnal penile tumescence and rigidity in the evaluation of male erectile dysfunction. Urol Clin North Am. 1995;22:775–88.

    PubMed  CAS  Google Scholar 

  92. Levine LA, Carroll RA. Nocturnal penile tumescence and rigidity in men without complaints of erectile dysfunction using a new quantitative analysis software. J Urol. 1994;152:1103–7.

    PubMed  CAS  Google Scholar 

  93. Heaton JP, Morales A. Facts and controversies of the application of penile tumescence and rigidity: recording for erectile dysfunction. In: Hellstrom WJG, editor. Male infertility and sexual dysfunction. New York: Springer; 1997. p. 579.

    Google Scholar 

  94. Incrocci L, Hop WCJ, Slob AK. Visual erotic and vibrotactile stimulation and intracavernous injection in screening men with erectile dysfunction: a 3-year experience with 406 cases. Int J Impot Res. 1996;8:227–32.

    PubMed  CAS  Google Scholar 

  95. Pridal CG, Lopiccolo J. Multi element treatment of desire disorders: integration of cognitive, behaviors, and systemic therapy. In: Leiblum SR, Rosen RC, editors. Principles and practice of sex therapy. 3rd ed. New York: Guilford; 2000.

    Google Scholar 

  96. Rubio-Aurioles E. Hypoactive sexual desire in men. In: Porst H, Buvat J, International Society for Sexual Medicine, editor. Standard practice in sexual medicine. Malden: Blackwell; 2006. p. 149–57.

    Google Scholar 

  97. Laumann EO, Nicolosi A, Glasser DB, et al. Sexual problems among women and men aged 40–80 years: prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors. Int J Impot Res. 2005;17:39–57.

    PubMed  CAS  Google Scholar 

  98. Meuleman EJ, Van Lankvled J. Hypoactive sexual desire disorder: an underestimated condition in men. BJU Int. 2005;95:201–96.

    Google Scholar 

  99. Schiavi RC. Normal aging and the evaluation of sexual dysfunction. Psychiatr Med 1992;10(2):2 17–25

    Google Scholar 

  100. deGroat WC, Booth AM. Physiology of male sexual function. Ann Intern Med. 1980;92:329–31.

    PubMed  CAS  Google Scholar 

  101. Hollenbeck BK, Dunn RL, Wei JT, Montie JE, Sand MG. Determinants of long-term sexual health outcome after radical prostatectomy measured by a validated instrument. J Urol. 2003;169:1453–7.

    PubMed  Google Scholar 

  102. Koema M, van Driel MF, Schultz WC, Mensink HJ. Orgasm after radical prostatectomy. Br J Urol. 1996;77:861–4.

    Google Scholar 

  103. Barnas JL, Pierpaoli S, Ladd P, Valenzuela R, et al. The prevalence and nature of orgasmic dysfunction after radical prostatectomy. BJU Int. 2004;94:603–5.

    PubMed  Google Scholar 

  104. Choi JM, Nelson CJ, Stasi J, Mulhall JP. Orgasm associated incontinence (climacturia) following radical pelvic surgery: rates of occurrence and predictors. J Urol. 2007;177:2223–6.

    PubMed  Google Scholar 

  105.  Dubbelman Y, Wildhagen M, Schroeder F, Bangma C, Dohle G. J Sex Med. 2010;7(3):1216–23.

    PubMed  CAS  Google Scholar 

  106. Barnas J, Parker M, Guhring P, Mulhass JP. The utility of tamsulosin in the management of orgasm-associated pain: a pilot analysis. Eur Urol. 2005;47:361–5.

    PubMed  CAS  Google Scholar 

  107. Lowentritt Bh, Scarino PT, Miles BJ, et al. Sildenafil citrate after radical retropubic prostatectomy. J Urol. 1999;162:1614–7.

    PubMed  CAS  Google Scholar 

  108. Rowland DL, Van Diest S, Incrocci I, Slob AK. Psychosexual factors that differentiate men with inhibited ejaculation from men with no dysfunction or men with another dysfunction. J Sex Med. 2005;2:289–383.

    Google Scholar 

  109. Perelman M. Retarded ejaculation. Curr Sex Health Rep. 2004;1(3):95–101.

    Google Scholar 

  110. Harbour R, Miller J. A new system for grading recommendations in evidence-based guidelines. BMJ. 2001;323:334–6.

    PubMed  CAS  Google Scholar 

  111. Broderick GA. Vascular assessment of erectile dysfunction. In: Lue TF, editor. Atlas of male sexual dysfunction. Philadelphia: Current Medicine LLC; 2004. p. 37.

    Google Scholar 

  112. Montorsi F, Adaikan G, Becher E, Giuliano F, Khoury S, Lue TF, Sharlip I, Althof SE, Andersson K-E, Brock GE, Broderick G, et al. Summary of the recommendations on Sexual Dysfunctions in Men: Committee Report International Consultation on Sexual Medicine 2009. J Sex Med. 2010;7:3572–88.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL, 32224, USA

    Gregory A. Broderick

Authors
  1. Gregory A. Broderick
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gregory A. Broderick .

Editor information

Editors and Affiliations

  1. Sexual Medicine Program, Memorial Sloan-Kettering Cancer Center, East 68th Street 353, New York, 10021, New York, USA

    John P. Mulhall

  2. Daniel den Hoed Cancer Center, Dept. Radiation Oncology, Erasmus Medical Center, Groene Hilledijk 301, Rotterdam, 3075 EA, Netherlands

    Luca Incrocci

  3. Alvarado Hospital, Alvarado Road 6719, San Diego, 92120, California, USA

    Irwin Goldstein

  4. New England Research Institutes, Galen Street 9, Watertown, 02472, Massachusetts, USA

    Ray Rosen

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Broderick, G.A. (2011). Evaluation of Male Sexual Dysfunction. In: Mulhall, J., Incrocci, L., Goldstein, I., Rosen, R. (eds) Cancer and Sexual Health. Current Clinical Urology. Humana Press. https://doi.org/10.1007/978-1-60761-916-1_24

Download citation

  • DOI: https://doi.org/10.1007/978-1-60761-916-1_24

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-60761-915-4

  • Online ISBN: 978-1-60761-916-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation